Medical ventilator

Global Ventilator Market (By Mobility, Interface, Mode & Application): Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

Retrieved on: 
Monday, May 4, 2020
Medicine, Respiratory therapy, Medical specialties, Health care, Mechanical ventilation, Medical ventilator, Invasive species

The global ventilator market by type can be segmented into the following: non-invasive and invasive.

Key Points: 
  • The global ventilator market by type can be segmented into the following: non-invasive and invasive.
  • The global ventilator market by mode can be segmented into the following: combined, volume and pressure, with the dominant share held by combined mode.
  • The global ventilator market by region can be segmented into the following regions: North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
  • The report provides a comprehensive analysis of the global ventilator market with potential impact of COVID-19.

Vyaire Medical and Spirit AeroSystems Partner to Greatly Increase Ventilator Production in Response to COVID-19 Pandemic

Retrieved on: 
Monday, May 4, 2020
Medical ventilator, Respiratory therapy, Spirit AeroSystems, Companies

The temporary special partnership will allow Vyaire to quickly ramp up production of critical care ventilators.

Key Points: 
  • The temporary special partnership will allow Vyaire to quickly ramp up production of critical care ventilators.
  • This partnership furthers earlier action taken by Vyaire to accelerate production of ventilators and other related respiratory equipment at its primary production facilities based in North America.
  • For more information, please visit our website, which will be updated as our pandemic response evolves: Vyaire COVID-19 Response Center .
  • Spirit AeroSystems focuses on affordable, innovative composite and aluminum manufacturing solutions to support customers around the globe.

VentFree™ Respiratory Muscle Stimulator Receives FDA Emergency Use Authorization for Use During COVID-19 Pandemic

Retrieved on: 
Monday, May 4, 2020
Biotechnology, Nursing, Health, FDA, Medical devices, Infectious diseases, Hospitals, Clinical trials, Health, Respiratory therapy, Medicine, Medical ventilator, Food and Drug Administration, Emergency Use Authorization, Anesthesia, Emergency Use Authorization of VentFree, Liberate Medical

Fewer days on ventilation may also increase the availability of ventilators during the COVID-19 pandemic.

Key Points: 
  • Fewer days on ventilation may also increase the availability of ventilators during the COVID-19 pandemic.
  • Last year VentFree received FDA Breakthrough Device Designation and CE marking in the European Union.
  • Current methods of respiratory muscle training cannot be used when patients are sedated or delirious, which is common among critically ill patients.
  • VentFree has been authorized for the above emergency use by FDA under an Emergency Use Authorization.

Sermo Reports: 50% of Highly Experienced COVID Treaters Believe COVID-19 Is More of an “Oxygen Failure” Disease vs. a Respiratory Disease Leading to ARDS; 48% Believe Ventilators Used Too Rapidly

Retrieved on: 
Monday, May 4, 2020
Women, Managed care, MEN, General Health, Health, Medical devices, Infectious diseases, Consumer, Health, Respiratory therapy, Hospital departments, Intensive care medicine, Medical ventilator, Intensive care unit

Panic buying of ventilators and competition among states to procure ventilators was intense at the onset of the COVID-19 outbreak.

Key Points: 
  • Panic buying of ventilators and competition among states to procure ventilators was intense at the onset of the COVID-19 outbreak.
  • Dr. Cameron Kyle-Sidell, a New York-based ER and critical care physician widely broadcast a compelling message on YouTube, we are treating the wrong disease.
  • Nine days ago I opened an intensive care unit to care for the sickest COVID patients.
  • And yet, everything Ive seen in the last 9 days just doesnt make sense...I believe we are treating the wrong disease.

Global Ventilator Market: Competitive Landscape

Retrieved on: 
Thursday, April 30, 2020
Medicine, Medical specialties, Health care, Respiratory therapy, Intensive care medicine, Emergency medicine, Medical ventilator, Mechanical ventilation

What is the change witnessed in the growth rate of the global ventilator market from pre-COVID to post-COVID scenario?

Key Points: 
  • What is the change witnessed in the growth rate of the global ventilator market from pre-COVID to post-COVID scenario?
  • What are the opportunities and challenges faced by healthcare and non-healthcare companies within the global ventilator market?
  • What was the market share of each of the companies in mechanical ventilator and non-invasive ventilator segments of the global ventilator market in 2019?
  • The global ventilator market is witnessing an exponential rise in the size of the market due to the ongoing COVID-19 pandemic.

Tennessee Company Develops Reliable Emergency Ventilator Amid Global Shortage for Developing Nations in Remote Field Hospitals Around the World

Retrieved on: 
Thursday, April 30, 2020
Respiratory therapy, Health, Medical ventilator, Medicine, Food and Drug Administration, Emergency Use Authorization, Mechanical ventilation, Medical equipment

The XVENT is a continuous, positive pressure ventilator that is capable of assisting a patient with respiratory insufficiency or respiratory failure.

Key Points: 
  • The XVENT is a continuous, positive pressure ventilator that is capable of assisting a patient with respiratory insufficiency or respiratory failure.
  • "That evening, I challenged my team to design and build a ventilator that is reliable, affordable, and deployable in any remote hospital around the world.
  • Breathe Strong, LLC, a subsidiary of Enexor BioEnergy, an organic waste-to-energy company based in Franklin, Tennessee, manufactures the XVENT ventilator.
  • Breathe Strong submitted a request for Emergency Use Authorization (EUA) by the FDA and will submit for final FDA approval in June.

CytoDyn Reports Strong Results from eIND COVID-19 Patients Treated with Leronlimab; Majority of Patients Have Demonstrated Remarkable Recoveries

Retrieved on: 
Thursday, April 30, 2020
Medicine, Clinical medicine, Medical specialties, Respiratory therapy, Intensive care medicine, First aid, Anesthesia, Otorhinolaryngology, Tracheal intubation, Medical ventilator

All patient blood samples were evaluated and important powerful results from the effect of leronlimab were demonstrated in almost all of these patients.

Key Points: 
  • All patient blood samples were evaluated and important powerful results from the effect of leronlimab were demonstrated in almost all of these patients.
  • Twenty-three (23) patients in Southern California hospital: Six patients were in critical condition (intubated) and 17 patients were severely-ill, needing oxygen support.
  • Of these 3 patients, 2 were extubated (taken off ventilator) and 1 patient remains on a ventilator but improving.
  • Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn said, We believe these results, although anecdotal, are very impressive and the number of patients treated under eIND is rapidly increasing.

AIS Healthcare Goes Above and Beyond to Supply Needed Medication for COVID-19 Ventilator Patients

Retrieved on: 
Wednesday, April 29, 2020
Hospitals, Pharmaceutical, Health, Drugs, Health care, Organic compounds, Respiratory therapy, Anilides, Citrates, Fentanyl, RTT, Medical ventilator

AIS Healthcare has provided fentanyl to hospitals in Georgia, Maryland and Washington, D.C.

Key Points: 
  • AIS Healthcare has provided fentanyl to hospitals in Georgia, Maryland and Washington, D.C.
    We want to help and we are thrilled that we could help the healthcare community, said Blaine Forshage, Chief Commercial Officer of AIS Healthcare.
  • The growing number of COVID-19 patients on ventilators has exhausted the supply of these medications at many hospitals and traditional suppliers are unable to meet current needs.
  • AIS Healthcares state-of-the-art facilities are fully equipped to compound these specialty medications for ventilator patients with COVID-19.
  • For example, when Chief Executive Officer Simon Castellanos learned that Phoebe Putney Health System in Georgia needed fentanyl for its ventilator patients, he quickly took action.

AAC and COVID-19: Ventilator Use May Necessitate Alternative Methods of Communication for Patients in Acute Care

Retrieved on: 
Wednesday, April 29, 2020
Medicine, Medical specialties, Health, Respiratory therapy, Intensive care medicine, Emergency medicine, Mechanical ventilation, Medical ventilator

The need for AAC is heightened by the fact that patients in acute care may not have loved ones around who would normally advocate for their care.

Key Points: 
  • The need for AAC is heightened by the fact that patients in acute care may not have loved ones around who would normally advocate for their care.
  • Many COVID-19 patients in serious condition require a mechanical ventilator to help them breathe while in acute care.
  • Patients and their family members should know that they have a right to communicate and that there are effective communication options via AAC.
  • To learn more about communication and AAC for people who are now or who were ventilator dependent, visit ASHA's website here .

New Capricor Data Reports 100 Percent Survival in Critical COVID-19 Patients Treated with CAP-1002

Retrieved on: 
Wednesday, April 29, 2020
Medicine, Health, Medical specialties, Respiratory therapy, Clinical research, Mechanical ventilation, Intensive care medicine, Design of experiments, Medical ventilator, Placebo-controlled study, Placebo

Following a review of the available data, the U.S. Food and Drug Administration (FDA) approved the Companys expanded access protocol to treat up to 20 additional COVID-19 patients.

Key Points: 
  • Following a review of the available data, the U.S. Food and Drug Administration (FDA) approved the Companys expanded access protocol to treat up to 20 additional COVID-19 patients.
  • There is also a randomized, placebo-controlled trial planned to treat patients with moderate and severe disease which is intended to be funded by non-equity capital.
  • Of the five patients on ventilator support, four patients no longer required ventilator support within just one to four days following the infusion.
  • The fifth patient remains on mechanical ventilation and the sixth patient is receiving supplemental oxygen and is currently clinically stable.